Janney Montgomery Scott LLC Xeris Biopharma Holdings, Inc. Transaction History
Janney Montgomery Scott LLC
- $35.8 Billion
- Q3 2024
A detailed history of Janney Montgomery Scott LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 17,500 shares of XERS stock, worth $58,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,500
Previous 10,750
62.79%
Holding current value
$58,975
Previous $24,000
108.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
142Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.2 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.7 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $458M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...